[Remote] Pharmacovigilance Scientist at Abata Therapeutics

Waltham, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Advanced degree in life sciences (e.g., PharmD, PhD) or related field
Minimum of 3 years of experience within the pharmaceutical industry, ideally including drug safety experience
Knowledge of good pharmacovigilance practices, drug safety regulations, and clinical trial processes
Proficient with safety surveillance systems and tools (e.g., Argus, MedDRA, Veeva Vault)

Responsibilities

Collects, reviews, and analyzes adverse event reports from clinical trials to identify potential safety signals
Supports quality control review of individual case safety reports (ICSRs)
Assists in ongoing safety monitoring activities, including data reconciliation and quality checks to ensure accuracy of safety data
Supports safety data management activities, including case processing, follow-up, and coding of adverse events
Assesses clinical safety data to identify, evaluate, and document adverse events and emerging safety concerns
Contributes to risk-benefit analyses and supports the development of risk mitigation strategies
Supports the preparation and review of pharmacovigilance documents such as Development Safety Update Reports (DSURs), development Risk Management Plans (dRMPs), and relevant sections of clinical trial protocols, IBs and regulatory submissions
Maintains current knowledge of relevant therapeutic areas, pharmacology, and drug safety regulations
Conducts literature reviews and safety signal assessments to inform safety evaluations
Works closely with clinical operations, regulatory affairs, medical affairs, data management, bioinformatics and project management teams to ensure comprehensive safety oversight
Supports compliance with global pharmacovigilance regulations and company safety policies
Supports the communication and oversight of pharmacovigilance and contract research organization vendors
Supports the project management of safety activities such as aggregate reports, safety team meetings, signal evaluations, etc

Skills

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free